A Single Dose of Recombinant Activated Factor VII (NovoSeven) Did Not Impair the Function of the Coronary Artery Bypass Grafts : Successful Treatment of Critical Bleeding after Cardiac Surgery in Two Cases

Giselher Pfau,Thomas F. Schilling,Alf Kozian,Christof Huth,C. Schneemilch,Marcell U. Heim

A Single Dose of Recombinant Activated Factor VII (NovoSeven) Did Not Impair the Function of the Coronary Artery Bypass Grafts : Successful Treatment of Critical Bleeding after Cardiac Surgery in Two Cases

2007

Giselher Pfau
Thomas F. Schilling
Alf Kozian
Christof Huth
C. Schneemilch
Marcell U. Heim

Bleeding disorders and hemorrhages cause considerable morbidity and mortality in cardiac surgical patients. Possible thromboembolic complications make the use of recombinant activated factor VII (r

Keywords:

Cardiac surgery
Cardiopulmonary bypass
Artery
Activated factor VII
Bypass grafts
Surgery
Medicine
Recombinant DNA
surgical patients

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations